Harmony Biosciences Holdings, Inc. Common Stock (HRMY) Stock Price, Quote & AI Analysis
Live HRMY stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Harmony Biosciences Holdings, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Harmony Biosciences Holdings, Inc. Common Stock (HRMY), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Harmony Biosciences Holdings, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Harmony Biosciences Holdings, Inc. Common Stock Overview
Company information
Company Overview
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Harmony Biosciences Holdings, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...